Macquarie Group LTD Insmed Inc Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

A detailed history of Macquarie Group LTD transactions in Insmed Inc stock. As of the latest transaction made, Macquarie Group LTD holds 2,746,628 shares of INSM stock, worth $206 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

2,746,628

Previous 3,899,504 29.56%

Holding current value

$206 Million

Previous $106 Million 73.95%

% of portfolio

0.22%

Previous 0.12%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$22.0 - $69.71 $25.4 Million - $80.4 Million	-1,152,876 Reduced 29.56%	2,746,628 $184 Million
Q1 2024 May 14, 2024	SELL	$25.72 - $29.94 $19.3 Million - $22.5 Million	-751,988 Reduced 16.17%	3,899,504 $106 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $53,397 - $72,367	-2,280 Reduced 0.05%	4,651,492 $144 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $5.22 Million - $7.07 Million	262,692 Added 5.98%	4,653,772 $118 Million
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $5.57 Million - $7.15 Million	338,716 Added 8.36%	4,391,080 $92.7 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $6.53 Million - $8.73 Million	401,559 Added 11.0%	4,052,364 $69.1 Million
Q4 2022 Feb 21, 2023	BUY	$16.98 - $23.15 $1.58 Million - $2.15 Million	92,881 Added 2.61%	3,650,805 $72.9 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $1.23 Million - $1.66 Million	58,914 Added 1.68%	3,557,924 $76.7 Million
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $2.12 Million - $3.19 Million	123,905 Added 3.67%	3,499,010 $69 Million
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $3.99 Million - $5.49 Million	195,222 Added 6.14%	3,375,105 $79.3 Million
Q4 2021 Feb 11, 2022	SELL	$25.89 - $33.45 $5.06 Million - $6.54 Million	-195,383 Reduced 5.79%	3,179,883 $86.6 Million
Q3 2021 Nov 12, 2021	BUY	$22.46 - $29.47 $4.17 Million - $5.47 Million	185,631 Added 5.82%	3,375,266 $93 Million
Q2 2021 Aug 13, 2021	BUY	$24.17 - $36.01 $70.7 Million - $105 Million	2,927,018 Added 1114.56%	3,189,635 $90.8 Million
Q1 2021 May 14, 2021	BUY	$32.28 - $44.3 $8.33 Million - $11.4 Million	258,030 Added 5625.25%	262,617 $8.94 Million
Q2 2020 Aug 11, 2020	BUY	$14.11 - $29.42 $64,722 - $134,949	4,587 New	4,587 $126,000
Q3 2018 Nov 15, 2018	SELL	$18.95 - $28.08 $1.33 Million - $1.97 Million	-70,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $1.4 Million - $2.08 Million	70,000 New	70,000 $1.66 Million

Others Institutions Holding INSM

# of Institutions

447

Shares Held

170M

Call Options Held

5.79M

Put Options Held

5.18M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.2B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Insmed Inc Transaction History